Cablegate: Price Freeze Imposed On Medicines and Medical


DE RUEHKV #1832 2941414
R 211414Z OCT 09



E.O. 12958: N/A

1. (U) Summary. Ukraine's parliament has enacted a new law
fixing prices of imported medicines and medical products at
their July 1, 2008 levels. Prices of domestically produced
medicines would be regulated by the GOU under the
legislation. Industry analysts expect the law would
negatively impact the 2 billion USD pharmaceutical industry
and create market shortages, but indications are that
President Yuschenko will veto the legislation. End Summary.

2. (U) The Verkhovna Rada passed Draft Law no. 3426 into law,
setting a moratorium on the increase in prices for
pharmaceuticals and medical products. The bill was
registered by two Communist Party deputies, Pyotr Simonenko
and Vladimir Matveev, in December, 2008, following sharp
local-currency price increases (42.2% over the past 12
months) on medicines, largely due to the devaluation of the
Ukrainian hryvnia (UAH). Until the GOU introduces official
price lists for domestic pharmaceuticals and medical
products, those items will also be set at their July 1, 2008
UAH prices. Medicines made domestically will be sold at
prices regulated by the GOU, while the prices of imported
medicines will be fixed at their local-currency prices as of
July 1, 2008.

3. (U) Imported medicines make up 65% of the 2 billion USD
Ukrainian market. Medical importers do not have significant
back stock purchased at July 2008 prices, and analysts expect
that new deliveries will be suspended, causing shortages and
industry losses of approximately UAH 6-7 billion (750 million
USD). When the Cabinet of Ministers established limits on
profit margins for medications in December 2008, pharmacies
saw the volume of imports drop and even basic imported
medicines, such as imported antibiotics, became more
difficult to find for consumers. The limits are still in
effect, through local business sources indicate that they are
no longer being enforced. The head of global pharmaceutical
firm AstraZeneca's Ukrainian branch, Vladimir Ignatov, said
that imports will not be possible if the law is implemented,
unless the GOU subsidizes distributors who incur losses or
offers a special optimal exchange rate for importers. The
medical importers' lobby attempted unsuccessfully to prevent
the adoption of the bill on the second reading, and is now
pinning hopes on a promised presidential veto and challenges
to the law's constitutional validity.

4. (SBU) Comment. Since resuming its legislative functions
in early October, the Verkhovna Rada has pushed forward a
number of populist bills. With Ukraine,s presidential
election coming in January 2010, it appears that, in this
instance, Ukraine,s parliamentarians are attempting to curry
favor with the electorate with price controls. End comment.

© Scoop Media

World Headlines


UN: India’s New COVID-19 Wave Is Spreading Like ‘Wildfire’, Warns UN Children’s Fund

7 May 2021 A new wave of COVID-19 infections is spreading like “wildfire” across India, leaving many youngsters destitute, the UN Children’s Fund UNICEF said on Friday. In the last 24 hours, India registered 3,915 coronavirus deaths and 414,188 ... More>>

UN: Decades Of Health Gains At Risk In Brazil Due To COVID-19

Although COVID-19 cases are declining in Brazil, the pandemic is putting decades of public health gains there at risk, the head of the World Health Organization ( WHO ) said on Friday. With global attention and support focused this week ... More>>

UN Report: Myanmar Approaching Point Of Economic Collapse

The turmoil following the military coup in Myanmar, coupled with the impact of COVID-19 could result in up to 25 million people – nearly half of the country’s population, living in poverty by early next year, a United Nations report said on Friday. That ... More>>

Focus On: UN SDGs

Study: Cut Methane Emissions To Avert Global Temperature Rise

6 May 2021 Methane emissions caused by human activity can be reduced by up to 45 per cent this decade, thus helping to keep global temperature rise to 1.5 degrees Celsius in line with the Paris Agreement on climate change, according to a UN-backed ... More>>

UN: Learning From COVID-19, Forum To Highlight Critical Role Of Science, Technology And Innovation In Global Challenges

New York, 4 May —To build on the bold innovations in science, technology and innovations that produced life-saving solutions during the COVID-19 pandemic, the UN will bring together experts to highlight measures that can broaden the development and deployment ... More>>

What COVID-19 Has Taught Us: “Healthcare Can No Longer Exist Without Technology”

A grandmother in a village in the Gambia should have the same quality of life and access to healthcare they deserve as in New York or London. Photo: InnovaRx Global Health Start-up Works To Bridge Healthcare Gap In The Gambia By: Pavithra Rao As ... More>>